prikaz prve stranice dokumenta Association of Nonalcoholic Fatty Liver Disease With COVID-19 Severity and Pulmonary Thrombosis: CovidFAT, a Prospective, Observational Cohort Study
Pristup korisnicima matične ustanove
Znanstveni rad - Izvorni znanstveni rad
Association of Nonalcoholic Fatty Liver Disease With COVID-19 Severity and Pulmonary Thrombosis: CovidFAT, a Prospective, Observational Cohort Study
Open Forum Infectious Diseases, 9 (2022), 4; X. https://doi.org/10.1093/ofid/ofac073
Vrsaljko, Nina; Samadan, Lara; Višković, Klaudija; Mehmedović, Armin; Budimir, Jelena; Vince, Adriana; Papić, Neven

Citirajte ovaj rad

Vrsaljko, N., Samadan, L., Višković, K., Mehmedović, A., Budimir, J., Vince, A. i Papić, N. (2022). Association of Nonalcoholic Fatty Liver Disease With COVID-19 Severity and Pulmonary Thrombosis: CovidFAT, a Prospective, Observational Cohort Study. Open Forum Infectious Diseases, 9. (4). doi: 10.1093/ofid/ofac073

Vrsaljko, Nina, et al. "Association of Nonalcoholic Fatty Liver Disease With COVID-19 Severity and Pulmonary Thrombosis: CovidFAT, a Prospective, Observational Cohort Study." Open Forum Infectious Diseases, vol. 9, br. 4, 2022. https://doi.org/10.1093/ofid/ofac073

Vrsaljko, Nina, Lara Samadan, Klaudija Višković, Armin Mehmedović, Jelena Budimir, Adriana Vince i Neven Papić. "Association of Nonalcoholic Fatty Liver Disease With COVID-19 Severity and Pulmonary Thrombosis: CovidFAT, a Prospective, Observational Cohort Study." Open Forum Infectious Diseases 9, br. 4 (2022). https://doi.org/10.1093/ofid/ofac073

Vrsaljko, N., et al. (2022) 'Association of Nonalcoholic Fatty Liver Disease With COVID-19 Severity and Pulmonary Thrombosis: CovidFAT, a Prospective, Observational Cohort Study', Open Forum Infectious Diseases, 9(4). doi: 10.1093/ofid/ofac073

Vrsaljko N, Samadan L, Višković K, Mehmedović A, Budimir J, Vince A, i sur.. Association of Nonalcoholic Fatty Liver Disease With COVID-19 Severity and Pulmonary Thrombosis: CovidFAT, a Prospective, Observational Cohort Study. Open Forum Infectious Diseases [Internet]. 01.04.2022. [pristupljeno 23.12.2024.];9(4). doi: 10.1093/ofid/ofac073

N. Vrsaljko, et al., "Association of Nonalcoholic Fatty Liver Disease With COVID-19 Severity and Pulmonary Thrombosis: CovidFAT, a Prospective, Observational Cohort Study", Open Forum Infectious Diseases, vol. 9, br. 4, Travanj 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:264613. [Citirano: 23.12.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:264613
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Association of Nonalcoholic Fatty Liver Disease With COVID-19 Severity and Pulmonary Thrombosis: CovidFAT, a Prospective, Observational Cohort Study
AutorNina Vrsaljko
AutorLara Samadan
AutorKlaudija Višković
AutorArmin Mehmedović
AutorJelena Budimir
AutorAdriana Vince
AutorNeven Papić
Autorova ustanovaSveučilište u Rijeci
Fakultet zdravstvenih studija
(Katedra za laboratorijsku i radiološku dijagnostiku)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Sažetak (engleski)
Background: Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease associated with systemic changes in immune response, which might be associated with coronavirus disease 2019 (COVID-19) severity. The aim of this study was to investigate the impact of NAFLD on COVID-19 severity and outcomes. Methods: A prospective observational study included consecutively hospitalized adult patients, hospitalized between March and June 2021, with severe COVID-19. Patients were screened for fatty liver by ultrasound and subsequently diagnosed with NAFLD. Patients were daily followed until discharge, and demographic, clinical, and laboratory data were collected and correlated to clinical outcomes. Results: Of the 216 patients included, 120 (55.5%) had NAFLD. The NAFLD group had higher C-reactive protein (interquartile range [IQR]) (84.7 [38.6-129.8] mg/L vs 66.9 [32.2-97.3] mg/L; P=.0340), interleukin-6 (49.19 [22.66-92.04] ng/L vs 13.22 [5.29-39.75] ng/L; P[removed]
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaOpen Forum Infectious Diseases
Brojčani podacivol. 9, br. 4, X
e-ISSN2328-8957
DOIhttps://doi.org/10.1093/ofid/ofac073
URN:NBNurn:nbn:hr:184:264613
Datum objave publikacije2022-04-01
URL dokumentahttps://academic.oup.com/ofid/article/doi/10.1093/ofid/ofac073/6524775
Vrsta resursaTekst
Prava pristupaInstitucijski pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2024-01-15 10:41:16